Skip to main content
. 2020 Oct 14;12:10163–10172. doi: 10.2147/CMAR.S270328

Figure 7.

Figure 7

SNHG7 targeted miR-186 to reverse trastuzumab resistance of breast cancer cells, inhibit the proliferation, migration, and EMT levels of breast cancer cells, and promote apoptosis.